DistantNews
Samsung Biologics strike continues for third day amid wage dispute
๐Ÿ‡ฐ๐Ÿ‡ท South Korea /Economy & Trade

Samsung Biologics strike continues for third day amid wage dispute

From Dong-A Ilbo · (1h ago) Korean Critical tone

Translated from Korean, summarized and contextualized by DistantNews.

TLDR

  • Samsung Biologics' labor union has been on a full-scale strike for three days, with approximately 70% of its 2,800 members participating.
  • The union is demanding a 14% average wage increase, a 30 million won bonus per person, and a 20% profit share.
  • The company claims the partial strike prior to the full walkout caused approximately 150 billion won in financial losses, affecting the production of critical treatments.

The labor dispute at Samsung Biologics has escalated, with the company's labor union initiating a full-scale strike that has now entered its third day. The walkout, involving a significant majority of the union's 2,800 members, underscores the deep divisions between labor and management over wage increases, bonuses, and profit-sharing.

This is a matter that infringes on management rights, and it is no different from the union trying to manage the company.

โ€” Samsung BiologicsThe company's response to the union's demand for prior consent on key management decisions.

The union's demands are substantial: a 14% average wage hike, a 30 million won bonus for each member, and 20% of operating profit to be distributed as performance-based pay. These demands reflect a strong push for greater financial recognition and a larger share of the company's success. In contrast, the company has offered a 6.2% wage increase and a one-time payment of 6 million won, a proposal that has clearly failed to bridge the gap.

Adding to the tension, Samsung Biologics has reported significant financial repercussions from the ongoing industrial action. The company estimates that a partial strike held just before the full walkout resulted in approximately 150 billion won in losses. This disruption has impacted the production of crucial treatments, including those for cancer and HIV, highlighting the serious consequences of the labor conflict on both the company's operations and the supply of essential medicines.

Supplement the collective agreement with promises of employment stability, increased staffing, and improvements to the performance evaluation system.

โ€” Samsung Biologics Labor UnionThe union's clarification of their demands regarding management issues.

From our perspective at Dong-A Ilbo, this strike is not just about wages; it touches upon fundamental issues of corporate governance and labor relations. The union's inclusion of demands for prior consent on key management decisions like hiring, performance reviews, and mergers raises concerns about potential infringements on management rights. While the union frames these as necessary for job security and fair practices, the company views them as an overreach. The upcoming negotiations, mediated by the Ministry of Employment and Labor, are critical in finding a resolution that balances the company's operational needs with the union's demands for fair compensation and a greater say in corporate affairs.

We will faithfully participate in the scheduled talks and do our utmost to restore peace to the workplace as soon as possible.

โ€” Samsung BiologicsThe company's official statement regarding the upcoming negotiations.
DistantNews Editorial

Originally published by Dong-A Ilbo in Korean. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.